Current therapeutic strategies in patients with oropharyngeal squamous cell carcinoma: Impact of the tumor hpv status

Abstract

Since there is no published randomized study comparing surgical and non‐surgical therapeutic strategies in patients with oropharyngeal squamous cell carcinoma (OPSCC), the therapeutic management of these patients remains highly controversial. While human papillomavirus (HPV)‐positive and HPV‐negative OPSCC are now recognized as two distinct diseases with different epidemiological, biological, and clinical characteristics, the impact of HPV status on the management of OPSCC patients is still unclear. In this review, we analyze the current therapeutic options in patients with OPSCC, highlighting the most recent advances in surgical and non‐surgical therapies, and we discuss the impact of HPV status on the therapeutic strategy.